4//SEC Filing
GARDNER PHYLLIS 4
Accession 0001479290-18-000079
CIK 0001479290other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 8:28 PM ET
Size
7.2 KB
Accession
0001479290-18-000079
Insider Transaction Report
Form 4
GARDNER PHYLLIS
Director
Transactions
- Award
Common Stock
2018-05-10+3,000→ 6,000 total - Award
Stock Option (Right to buy)
2018-05-10+6,000→ 6,000 totalExercise: $29.15Exp: 2028-05-09→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Represents an annual restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the one year anniversary, May 10, 2019, subject to Dr. Gardner's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date.
- [F2]The shares subject to the stock option shall vest on the one year anniversary, May 10, 2019, subject to Dr. Gardner's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001238646
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 8:28 PM ET
- Size
- 7.2 KB